PACB vs TXG
Pacific Biosciences of California, Inc. - Common Stock · 10x Genomics, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | PACB | TXG |
|---|---|---|
| Price | $1.34 | $72.68 |
| Market Cap | $416.51M | $9.28B |
| P/E | — | — |
| P/B | — | 11.24 |
| P/S | 2.60 | 14.44 |
| ROE | — | -5.3% |
| Net Margin | -341.5% | -6.8% |
| Gross Margin | 28.6% | 69.1% |
| Revenue Growth | 3.9% | 5.2% |
| Dividend Yield | — | — |
| EPS | -$1.76 | -$0.34 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.